Against the backdrop of high medical costs and an imbalance of access to care, is there reason to be optimistic about the ...
The financial struggles of genetic testing and ancestry company 23andMe are raising questions about the security of customers ...
Explore how the genetic testing industry is transforming healthcare through precision medicine ensuring patient privacy and ...
Orange County’s third largest medical diagnostics and testing company is being acquired by a fast-growing Chicago-based firm ...
Families requiring access to genetic testing and clinical genetic expertise are facing significant challenges due to long ...
The highest dose of an experimental pill developed by Eli Lilly dramatically lowered an inherited form of high cholesterol in ...
DNA commodification is no longer a future concern; it’s a present reality. Beyond charging users for their services, some ...
The future of 23andMe, a genetic testing company, is uncertain due to financial challenges and recent workforce reductions.
We recently published a list of UBS’ Top Quant Stocks In AI, IT, Healthcare & Other Sectors: Top 33 Stocks In All Sectors. In ...
The familial trend, it turned out, was linked to a genetic mutation. That meant Bill might also be at risk for the disease.
After initial review of the updated policy, the company ... order to receive genetic information that is unique to each patient. The GeneSight test supplements other information considered by a ...